Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Technology | Stents Peripheral | October 05, 2018

Veryan Medical's BioMimics 3D Stent Receives PMA Approval

October 5, 2018 — Veryan Medical Ltd has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent...

News | Vascular Closure Devices | October 05, 2018

Teleflex Acquires Essential Medical

October 5, 2018 — Teleflex Inc. announced the acquisition of Essential Medical Inc. Based in Exton, Pa., Essential...

News | Heart Failure | October 04, 2018

Ohio State First in U.S. to Test Shunt Device for Heart Failure

October 4, 2018 — The Ohio State University Wexner Medical Center is first in the country to test a new medical...

$The late-breaking FAST-FFR Trial demonstrated that the sensitivity and specificity of the CathWorks FFRangio angiography imaging derived fractional flow reserve (FFR-angio) technology matched the performance of wire-based FFR measurements. #TCT2018$

The late-breaking FAST-FFR Trial demonstrated that the sensitivity and specificity of the CathWorks FFRangio angiography imaging derived fractional flow reserve (FFR-angio) technology matched the performance of wire-based FFR measurements.

News | FFR Technologies | October 04, 2018

FAST-FFR Trial of FFR-angio Technology Meets Primary Endpoint, Exceeded Performance Goals

October 4, 2018 — The late-breaking FAST-FFR Trial demonstrated that the sensitivity and specificity of the...

Pulmonary artery denervation for CpcPH from the PADN-5 trial. #TCT2017

A series of procedural images of a pulmonary artery denervation for CpcPH from the PADN-5 trial.

News | Hypertension | October 04, 2018

Pulmonary Artery Denervation Significantly Improvements Hemodynamics in CpcPH

October 4, 2018 — Pulmonary artery denervation (PADN) is associated with significant improvements in hemodynamic and...

Technology | Medical 3-D Printing | October 04, 2018

Biomodex Announces New Training Solution for Left Atrial Appendage Closure

October 4, 2018 — Three-...

The Biotronik Osiro is an ultra thin strut, sirolimus-eluting stent. #TCT2018

The Biotronik Osiro is an ultra thin strut, sirolimus-eluting stent.

News | Stents | October 04, 2018

Orsiro Stent Performs in Two Comparison Studies Presented at TCT 2018

October 4, 2018 – Investigators unveiled clinical data from the independent BIONYX and SORT OUT IX all-comers trials...

Videos | TCT | October 03, 2018

VIDEO: Editor’s Choice of the Most Innovative New Technology at TCT 2018

DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technology he found on the...

News | Radiation Dose Management | October 03, 2018

Image Diagnostics Debuting Interventional Radiation Shield at RSNA 2018

October 3, 2018 — Image Diagnostics has entered into a product development agreement with ECLS Inc. to design a new...

One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon Stertzer, M.D. In this article he shares his views on the current direction and next steps in cardiovascular biomedical technology

Simon Stertzer, M.D., is one of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s and 1980s. He performed the first coronary balloon angioplasty in the United States in 1978.

Feature | October 03, 2018

How Biotechnology is Impacting the Treatment and Prevention of Heart Disease

One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was...